Find Research outputs

Search results

• A phase I trial of cyclosphosphamide and carboplatinum combined with interleukin-3 in women with advanced-stage ovarian cancer

  Speyer, J. L., Mandeli, J., Hochster, H., Runowicz, C., Wadler, S., Wallach, R., Cohen, C., Oette, D., Sorich, J., Demakos, E., Gelpke, L., Goldberg, G., Bruckner, H. & Holland, J., Mar 1995, In: Gynecologic Oncology. 56, 3, p. 387-394 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis

  Bartlett, D. L., Buell, J. F., Libutti, S. K., Reed, E., Lee, K. B., Figg, W. D., Venzon, D. J. & Alexander, H. R., Sep 15 1998, In: Cancer. 83, 6, p. 1251-1261 11 p.

  Research output: Contribution to journal › Article › peer-review
  32 Scopus citations

• A Phase I trial of combination chemotherapy employing carboplatin vinca alkaloids, with or without bleomcyin in patients with advanced malignant tumors

  Einzig, A., 1990, In: Cancer Investigation. 8, 2, p. 229-230 2 p.

  Research output: Contribution to journal › Editorial › peer-review

• A phase I trial of alfimeprase for peripheral arterial thrombolysis

  Ouriel, K., Cynamon, J., Weaver, F. A., Dardik, H., Akers, D., Blebea, J., Gruneiro, L., Toombs, C. F., Wang-Clow, F., Mohler, M., Pena, L., Wan, C. Y. & Deitcher, S. R., Aug 2005, In: Journal of Vascular and Interventional Radiology. 16, 8, p. 1075-1083 9 p.

  Research output: Contribution to journal › Article › peer-review
  40 Scopus citations

• A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumors

  Sklarin, N. T., Lathia, C. D., Benson, L., Grove, W. R., Thomas, S., Roca, J., Einzig, A. I. & Wiernik, P. H., 1997, In: Investigational New Drugs. 15, 3, p. 235-246 12 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• A Phase i Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer

  Halmos, B., Jia, Y., Bokar, J. A., Fu, P., Adelstein, D. J., Juergens, R., Rodal, M. B. & Dowlati, A., Oct 2013, In: Investigational New Drugs. 31, 5, p. 1244-1250 7 p.

  Research output: Contribution to journal › Article › peer-review
  7 Scopus citations

• A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer

  Kummar, S., Sitki Copur, M., Rose, M., Wadler, S., Stephenson, J., O'Rourke, M., Brenckman, W., Tilton, R., Liu, S. H., Jiang, Z., Su, T., Cheng, Y. C. & Chu, E., Jun 2011, In: Clinical colorectal cancer. 10, 2, p. 85-96 12 p.

  Research output: Contribution to journal › Article › peer-review
  79 Scopus citations

• A phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors

  Vokes, E. E., Goh, B. C., Bertucci, D., Vogelzang, N. J., Mani, S. & Ratain, M. J., Aug 1 1999, In: Cancer. 86, 3, p. 528-532 5 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis- acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days

  DeMario, M. D., Ratain, M. J., Vogelzang, N. J., Mani, S., Vokes, E. E., Fleming, G. F., Melton, K., Johnson, S., Benner, S. & Lebwohl, D., 1999, In: Cancer Chemotherapy and Pharmacology. 43, 5, p. 385-388 4 p.

  Research output: Contribution to journal › Article › peer-review
  12 Scopus citations

• A phase I study of high-dose interleukin-2 in combination with interferon-α_2b

  Sznol, M., Mier, J. W., Sparano, J., Gaynor, E. R., Weiss, G. R., Margolin, K. A., Bar, M. H., Hawkins, M. J., Atkins, M. B., Dutcher, J. P., Fisher, R. I., Boldt, D. H., Doroshow, J. H., Louie, A. & Aronson, F. R., Dec 1990, In: Journal of Biological Response Modifiers. 9, 6, p. 529-537 9 p.

  Research output: Contribution to journal › Article › peer-review
  34 Scopus citations

• A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer

  Fekrazad, H. M., Verschraegen, C. F., Royce, M., Smith, H. O., Lee, F. C. & Rabinowitz, I., Aug 1 2010, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 33, 4, p. 393-397 5 p.

  Research output: Contribution to journal › Article › peer-review
  12 Scopus citations

• A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies

  Goel, S., Mita, A. C., Mita, M., Rowinsky, E. K., Chu, Q. S., Wong, N., Desjardins, C., Fang, F., Jansen, M., Shuster, D. E., Mani, S. & Takimoto, C. H., Jun 15 2009, In: Clinical Cancer Research. 15, 12, p. 4207-4212 6 p.

  Research output: Contribution to journal › Article › peer-review
  129 Scopus citations

• A phase I study of DMS612, a novel bifunctional alkylating agent

  Appleman, L. J., Balasubramaniam, S., Parise, R. A., Bryla, C., Redon, C. E., Nakamura, A. J., Bonner, W. M., Wright, J. J., Piekarz, R., Kohler, D. R., Jiang, Y., Belani, C. P., Eiseman, J., Chu, E., Beumer, J. H. & Bates, S. E., Feb 15 2015, In: Clinical Cancer Research. 21, 4, p. 721-729 9 p.

  Research output: Contribution to journal › Article › peer-review
  6 Scopus citations

• A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia

  Schindler, J., Gajavelli, S., Ravandi, F., Shen, Y., Parekh, S., Braunchweig, I., Barta, S., Ghetie, V., Vitetta, E. & Verma, A., Aug 2011, In: British Journal of Haematology. 154, 4, p. 471-476 6 p.

  Research output: Contribution to journal › Article › peer-review
  77 Scopus citations

• A phase i study in patients with solid or hematologic malignancies of the dose proportionality of subcutaneous azacitidine and its pharmacokinetics in patients with severe renal impairment

  Laille, E., Goel, S., Mita, A. C., Gabrail, N. Y., Kelly, K., Liu, L., Songer, S. & Beach, C. L., May 2014, In: Pharmacotherapy. 34, 5, p. 440-451 12 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase I safety and dose escalation trial of docetaxel combined with GEM®231, a second generation antisense oligonucleotide targeting protein kinase A R1α in patients with advanced solid cancers

  Goel, S., Desai, K., MacApinlac, M., Wadler, S., Goldberg, G., Fields, A., Einstein, M., Volterra, F., Wong, B., Martin, R. & Mani, S., Mar 2006, In: Investigational New Drugs. 24, 2, p. 125-134 10 p.

  Research output: Contribution to journal › Article › peer-review
  37 Scopus citations

• A phase I randomized safety study of a single-size silicone rubber diaphragm used with or without a lactic-acid-containing diaphragm gel

  Thurman, A., Cunningham, T., Fichorova, R., Herold, B. C., Hillier, S. L., Chandra, N. & Doncel, G. F., Dec 2019, In: Contraception. 100, 6, p. 430-437 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

  Takebe, N., Beumer, J. H., Kummar, S., Kiesel, B. F., Dowlati, A., O'Sullivan Coyne, G., Piekarz, R., Rubinstein, L., Fogli, L. K., Vaishampayan, U., Goel, S., O'Bryant, C. L., El-Rayes, B. F., Chung, V., Lenz, H. J., Kim, R., Belani, C. P., Tuscano, J. M., Schelman, W., Moore, N., & 2 othersDoroshow, J. H. & Chen, A. P., Nov 1 2019, In: British Journal of Clinical Pharmacology. 85, 11, p. 2499-2511 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  9 Scopus citations

• A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation

  Girnius, S. K., Lee, S., Kambhampati, S., Rose, M. G., Mohiuddin, A., Houranieh, A., Zimelman, A., Grady, T., Mehta, P., Behler, C., Hayes, T. G., Efebera, Y. A., Prabhala, R. H., Han, A., Yellapragada, S. V., Klein, C. E., Roodman, G. D., Lichtenstein, A. & Munshi, N. C., Apr 1 2015, In: British Journal of Haematology. 169, 1, p. 36-43 8 p.

  Research output: Contribution to journal › Article › peer-review
  9 Scopus citations

• A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases

  Iwamoto, F. M., Omuro, A. M., Raizer, J. J., Nolan, C. P., Hormigo, A. L., Lassman, A. B., Gavrilovic, I. T. & Abrey, L. E., Mar 2008, In: Journal of Neuro-Oncology. 87, 1, p. 85-90 6 p.

  Research output: Contribution to journal › Article › peer-review
  37 Scopus citations

• A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: An Eastern Cooperative Oncology Group Trial

  Moulder, S., Li, H., Wang, M., Gradishar, W. J., Perez, E. A., Sparano, J. A., Pins, M., Yang, X. & Sledge, G. W., Feb 2010, In: Breast Cancer Research and Treatment. 119, 3, p. 663-671 9 p.

  Research output: Contribution to journal › Article › peer-review
  39 Scopus citations

• A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

  Herzog, T. J., Monk, B. J., Rose, P. G., Braly, P., Hines, J. F., Bell, M. C., Wenham, R. M., Secord, A. A., Roman, L. D., Einstein, M. H., Drake, R. D. & Childs, B. H., Mar 2014, In: Gynecologic Oncology. 132, 3, p. 517-525 9 p.

  Research output: Contribution to journal › Article › peer-review
  15 Scopus citations

• A phase II trial of m-AMSA in patients with small-cell lung cancer.

  Natale, R. B., Gralla, R. J. & Wittes, R. E., Dec 1981, In: Cancer clinical trials. 4, 4, p. 393-395 3 p.

  Research output: Contribution to journal › Article › peer-review

• A phase II trial of interleukin-12 in patients with advanced cervical cancer: Clinical and immunologic correlates: Eastern Cooperative Oncology Group study E1E96

  Wadler, S., Levy, D., Frederickson, H. L., Falkson, C. I., Wang, Y., Weller, E., Burk, R., Ho, G. & Kadish, A. S., Mar 2004, In: Gynecologic Oncology. 92, 3, p. 957-964 8 p.

  Research output: Contribution to journal › Article › peer-review
  47 Scopus citations

• A phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma

  Eng, C., Ramathan, R. K., Wong, M. K., Remick, S. C., Dai, L., Wade-Oliver, K. T., Mani, S. & Kindler, H. L., Dec 1 2004, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 27, 6, p. 565-569 5 p.

  Research output: Contribution to journal › Article › peer-review
  38 Scopus citations

• A phase ii trial of cetuximab, gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma

  Cetin, V., Piperdi, B., Bathini, V., Walsh, W. V., Yunus, S., Tseng, J. F., Whalen, G. F., Wassef, W. Y., Kadish, S. P., Fitzgerald, T. J., Mikule, C., Wang, Y. & Grossman, S. R., 2013, In: Gastrointestinal Cancer Research. 6, 4 SUPPL.1, p. 2-9 8 p.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations

• A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: An Eastern Cooperative Oncology Group Study (E1103)

  Li, T., Guo, M., Gradishar, W. J., Sparano, J. A., Perez, E. A., Wang, M. & Sledge, G. W., Jul 2012, In: Breast Cancer Research and Treatment. 134, 1, p. 345-352 8 p.

  Research output: Contribution to journal › Article › peer-review
  18 Scopus citations

• A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma

  Knox, J. J., Qin, R., Strosberg, J. R., Tan, B., Kaubisch, A., El-Khoueiry, A. B., Bekaii-Saab, T. S., Rousey, S. R., Chen, H. X. & Erlichman, C., Feb 2015, In: Investigational New Drugs. 33, 1, p. 241-246 6 p.

  Research output: Contribution to journal › Article › peer-review
  28 Scopus citations

• A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients

  Novetsky, A. P., Zighelboim, I., Guntupalli, S. R., Ioffe, Y. J. M., Kizer, N. T., Hagemann, A. R., Powell, M. A., Thaker, P. H., Mutch, D. G. & Massad, L. S., Aug 2014, In: Gynecologic Oncology. 134, 2, p. 233-237 5 p.

  Research output: Contribution to journal › Article › peer-review
  16 Scopus citations

• A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia

  Litzow, M. R., Lee, S., Bennett, J. M., Dewald, G. W., Gallagher, R. E., Jain, V., Paietta, E. M., Racevskis, J., Rousey, S. R., Mazza, J. J. & Tallman, M. S., Aug 2006, In: Haematologica. 91, 8, p. 1105-1108 4 p.

  Research output: Contribution to journal › Article › peer-review
  16 Scopus citations

• A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

  Navid, F., Santana, V. M., Neel, M., McCarville, M. B., Shulkin, B. L., Wu, J., Billups, C. A., Mao, S., Daryani, V. M., Stewart, C. F., Kunkel, M., Smith, W., Ward, D., Pappo, A. S., Bahrami, A., Loeb, D. M., Reikes Willert, J., Rao, B. N. & Daw, N. C., Oct 1 2017, In: International Journal of Cancer. 141, 7, p. 1469-1477 9 p.

  Research output: Contribution to journal › Article › peer-review
  36 Scopus citations

• A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers

  Gupta, D., Owers, R. L., Kim, M., Kuo, D. Y. S., Huang, G. S., Shahabi, S., Goldberg, G. L. & Einstein, M. H., Jun 2009, In: Gynecologic Oncology. 113, 3, p. 327-330 4 p.

  Research output: Contribution to journal › Article › peer-review
  21 Scopus citations

• A phase II study of taxol in patients with malignant melanoma

  Einzig, A. I., Hochster, H., Wiernik, P. H., Trump, D. L., Dutcher, J. P., Garowski, E., Sasloff, J. & Smith, T. J., Feb 1991, In: Investigational New Drugs. 9, 1, p. 59-64 6 p.

  Research output: Contribution to journal › Article › peer-review
  63 Scopus citations

• A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer

  Goel, S., Wadler, S., Hoffman, A., Volterra, F., Baker, C., Nazario, E., Ivy, P., Silverman, A. & Mani, S., Feb 2003, In: Investigational New Drugs. 21, 1, p. 103-107 5 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase ii study of pelareorep (REOLYSIN®) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma

  Mahalingam, D., Goel, S., Aparo, S., Arora, S. P., Noronha, N., Tran, H., Chakrabarty, R., Selvaggi, G., Gutierrez, A., Coffey, M., Nawrocki, S. T., Nuovo, G. & Mita, M. M., Jun 2018, In: Cancers. 10, 6, 160.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  73 Scopus citations

• A phase II study of high‐dose estrogens (diethylstilbestrol diphosphate) in prostate cancer

  Citrin, D. L., Kies, M. S., Wallemark, CB. B., Khandekar, J., Kaplan, E., Camacho, F. & Lind, R., Aug 1 1985, In: Cancer. 56, 3, p. 457-460 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

  Dutcher, J. P., Gaynor, E. R., Boldt, D. H., Doroshow, J. H., Bar, M. H., Sznol, M., Mier, J., Sparano, J., Fisher, R. I., Weiss, G., Margolin, K., Aronson, F. R., Hawkins, M. & Atkins, M., 1991, In: Journal of Clinical Oncology. 9, 4, p. 641-648 8 p.

  Research output: Contribution to journal › Article › peer-review
  80 Scopus citations

• A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

  Anderson, P. M., Bielack, S. S., Gorlick, R. G., Skubitz, K., Daw, N. C., Herzog, C. E., Monge, O. R., Lassaletta, A., Boldrini, E., Pápai, Z., Rubino, J., Pathiraja, K., Hille, D. A., Ayers, M., Yao, S. L., Nebozhyn, M., Lu, B. & Mauro, D., Oct 1 2016, In: Pediatric Blood and Cancer. 63, 10, p. 1761-1770 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  64 Scopus citations

• A phase II study of BEZ235 in patients with everolimusresistant, advanced pancreatic neuroendocrine tumours

  Fazio, N., Buzzoni, R., Baudin, E., Antonuzzo, L., Hubner, R. A., Lahner, H., De Herder, W. W., Raderer, M., Teulé, A., Capdevila, J., Libutti, S. K., Kulke, M. H., Shah, M., Dey, D., Turri, S., Aimone, P., Massacesi, C. & Verslype, C., Feb 2016, In: Anticancer Research. 36, 2, p. 713-720 8 p.

  Research output: Contribution to journal › Article › peer-review
  72 Scopus citations

• A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer

  Lacouture, M. E., Keefe, D. M., Sonis, S., Jatoi, A., Gernhardt, D., Wang, T., Doherty, J. P., Giri, N., Nadanaciva, S., O'Connell, J., Sbar, E., Piperdi, B. & Garon, E. B., Sep 1 2016, In: Annals of Oncology. 27, 9, p. 1712-1718 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  43 Scopus citations

• A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

  Katz, B., Oct 2005, In: Ophthalmology. 112, 10, p. 1747-1757 11 p.

  Research output: Contribution to journal › Article › peer-review
  545 Scopus citations

• A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

  Tu, Y., Hershman, D. L., Bhalla, K., Fiskus, W., Pellegrino, C. M., Andreopoulou, E., Makower, D., Kalinsky, K., Fehn, K., Fineberg, S., Negassa, A., Montgomery, L. L., Wiechmann, L. S., Alpaugh, R. K., Huang, M. & Sparano, J. A., Jul 2014, In: Breast Cancer Research and Treatment. 146, 1, p. 145-152 8 p.

  Research output: Contribution to journal › Article › peer-review
  43 Scopus citations

• A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver

  Alexander, H. R., Libutti, S. K., Bartlett, D. L., Puhlmann, M., Fraker, D. L. & Bachenheimer, L. C., Aug 1 2000, In: Clinical Cancer Research. 6, 8, p. 3062-3070 9 p.

  Research output: Contribution to journal › Article › peer-review
  131 Scopus citations

• A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer

  Arteaga, C. L., O'Neill, A., Moulder, S. L., Pins, M., Sparano, J. A., Sledge, G. W. & Davidson, N. E., Oct 1 2008, In: Clinical Cancer Research. 14, 19, p. 6277-6283 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  66 Scopus citations

• A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

  Gralla, R. J., Bosnjak, S. M., Hontsa, A., Balser, C., Rizzi, G., Rossi, G., Borroni, M. E. & Jordan, K., Jul 2014, In: Annals of Oncology. 25, 7, p. 1333-1339 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  149 Scopus citations

• A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

  Avidan, M. S., Levy, J. H., Scholz, J., Delphin, E., Rosseel, P. M. J., Howie, M. B., Gratz, I., Bush, C. R., Skubas, N., Aldea, G. S., Licina, M., Bonfiglio, L. J., Kajdasz, D. K., Ott, E. & Despotis, G. J., Feb 1 2005, In: Anesthesiology. 102, 2, p. 276-284 9 p.

  Research output: Contribution to journal › Article › peer-review
  102 Scopus citations

• A Phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinoma

  Hawkins, M. J., Atkins, M. B., Dutcher, J. P., Fisher, R. I., Weiss, G. R., Margolin, K. A., Rayner, A. A., Sznol, M., Parkinson, D. R., Paietta, E., Gaynor, E. R., Boldt, D. H., Doroshow, J. H. & Aronson, F. R., Jan 1994, In: Journal of Immunotherapy. 15, 1, p. 74-78 5 p.

  Research output: Contribution to journal › Article › peer-review
  28 Scopus citations

• A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

  Voss, T., Lipton, R. B., Dodick, D. W., Dupre, N., Ge, J. Y., Bachman, R., Assaid, C., Aurora, S. K. & Michelson, D., Aug 1 2016, In: Cephalalgia. 36, 9, p. 887-898 12 p.

  Research output: Contribution to journal › Article › peer-review
  187 Scopus citations

• A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer

  Camidge, D. R., Berge, E. M., Doebele, R. C., Ballas, M. S., Jahan, T., Haigentz, M., Hoffman, D., Spicer, J., West, H., Lee, P., Yang, L., Joshi, A., Gao, L., Yurasov, S. & Mita, A., Oct 1 2014, In: Journal of Thoracic Oncology. 9, 10, p. 1532-1539 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  50 Scopus citations

• A Phase i Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination with Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma

  Meyer, J., Arriaga, Y., Anandam, J., Karri, S., Syed, S., Verma, U., Abdelnaby, A., Raja, G., Dong, Y., Beg, M. S. & Balch, G., Oct 1 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 10, p. 972-976 5 p.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations